Evolent Health Inc Class A EVH
NYSE · United States · Commercial Services
$3.39-0.10 (-2.87%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
The past six months have been a windfall for Evolent Health’s shareholders. The company’s stock price has jumped 48.6%, hitting $3.70 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Expanded Partnership Strengthens Language Access and Provides Greater Visibility Across Evolent’s Payer Network Key Takeaways Enterprise-wide telephonic interpretation expands language access for members with limited English proficiency.Centralized reporting improves oversight of language services and supports compliance efforts.AI-enabled technology and professional interpreters deliver fast, reliable service. NEW YORK, Sept. 21, 2026 (GLOBE NEWSWIRE) -- TransPerfect, the world’s leading provid
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Looking back on healthcare technology for providers stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Evolent Health (NYSE:EVH) and its peers.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.